liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Gamma secretase inhibitors, DAPT and MK0752, exhibit synergistic anticancer effects with cisplatin and docetaxel in 2D and 3D models of breast cancer
Linköping University, Department of Biomedical and Clinical Sciences, Division of Clinical Chemistry and Pharmacology. Linköping University, Faculty of Medicine and Health Sciences. Istanbul Kultur Univ, Turkiye; Izmir Inst Technol, Turkiye.
Linköping University, Department of Biomedical and Clinical Sciences, Division of Clinical Chemistry and Pharmacology. Linköping University, Faculty of Medicine and Health Sciences.ORCID iD: 0000-0002-5645-3346
Linköping University, Department of Biomedical and Clinical Sciences, Division of Clinical Chemistry and Pharmacology. Linköping University, Faculty of Medicine and Health Sciences.ORCID iD: 0000-0001-6671-7600
Izmir Inst Technol, Turkiye.
2025 (English)In: Turkish Journal of Biology, ISSN 1300-0152, E-ISSN 1303-6092, Vol. 49, no 7Article in journal (Refereed) Published
Abstract [en]

Background/aim: Breast cancer remains a major malignancy among women, and severe side effects and the development of acquired drug resistance frequently hinder current therapeutic strategies. The Notch signaling pathway, a key regulator of cell fate, is commonly dysregulated in breast cancer and associated with poor prognosis. Gamma-secretase inhibitors (GSIs) block Notch receptor activation and have shown potential anticancer efficacy. This study aimed to investigate the synergistic activity of two commonly used GSIs, DAPT and MK0752, combined with docetaxel or cisplatin in both 2D and 3D breast cancer models. Materials and methods: Triple-negative, highly metastatic MDA-MB-231 and ER+/PR+ MCF-7 breast cancer cell lines were treated with DAPT or MK0752 alone or in combination with docetaxel or cisplatin. Drug efficacy and potential synergism were evaluated in 2D monolayer cultures and 3D spheroid models. Sequential treatment strategies were also assessed, where docetaxel or cisplatin was administered prior to GSI exposure. Results: Both MDA-MB-231 and MCF-7 cell lines exhibited notable sensitivity to DAPT and MK0752 combinations with docetaxel or cisplatin in 2D and 3D cultures. Synergistic enhancement of cytotoxicity was observed, particularly in sequential treatment regimens. Pretreatment with docetaxel or cisplatin followed by GSI exposure demonstrated superior growth inhibition compared with either monotherapy or simultaneous combination treatments. Conclusion: This study highlights the therapeutic potential of combining GSIs with standard chemotherapeutics to overcome drug resistance in breast cancer. The observed synergy and sequencing effects provide a strong basis for further mechanistic and translational investigations to optimize GSI-based combinational therapy strategies.

Place, publisher, year, edition, pages
Tubitak Scientific & Technological Research Council Turkey , 2025. Vol. 49, no 7
Keywords [en]
Notch signaling pathway; gamma secretase inhibitors; DAPT; MK0752; mammospheres
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-220971DOI: 10.55730/1300-0152.2776ISI: 001668966500001PubMedID: 41496856Scopus ID: 2-s2.0-105028109074OAI: oai:DiVA.org:liu-220971DiVA, id: diva2:2035052
Note

Funding Agencies|Izmir Institute of Technology [IYTE0221, 1059B142000543, 2214A]; Linkoeping University (LiU Cancer); TUBIdot;TAK 2214A project [1059B142000543]

Available from: 2026-02-03 Created: 2026-02-03 Last updated: 2026-03-29

Open Access in DiVA

fulltext(1694 kB)34 downloads
File information
File name FULLTEXT01.pdfFile size 1694 kBChecksum SHA-512
715022eaae87f5e709750aff8b1b2f087adea3ae1ccf3a471629ce1c0a119b1e839ca4e8c66935b058491eb04f2a634c4fe699079770a50d6c139298ff021927
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Telli, KübraGubat, JohannesD´arcy, Padraig
By organisation
Division of Clinical Chemistry and PharmacologyFaculty of Medicine and Health Sciences
In the same journal
Turkish Journal of Biology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 34 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 34 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf